{
  "docId": "019dd923-5efe-75c0-8dfe-f659060b287f",
  "docSlug": "bc4fb8cae61b29e3",
  "documentTitle": "2024 Investor Day",
  "authorId": "Revvity",
  "authorName": "Revvity",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 89,
  "pageCount": 109,
  "prevPage": 88,
  "nextPage": 90,
  "slideType": "case_study",
  "function": "illustrate_case",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": "The slide uses a scientific diagram to illustrate the mechanism of the base editing technology.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "callout_box",
    "infographic"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5efe-75c0-8dfe-f659060b287f/89",
  "deckHref": "/decks/019dd923-5efe-75c0-8dfe-f659060b287f",
  "deckJsonHref": "/decks/019dd923-5efe-75c0-8dfe-f659060b287f.json",
  "deckAnchorHref": "/decks/019dd923-5efe-75c0-8dfe-f659060b287f#slide-89",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.16,
        "y": 0.33
      },
      "kind": "callout",
      "text": "Pin-Point™ base editing is perfectly situated for a wide variety of future rare disease therapies",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e6da9601-9e8e-4350-a753-52ef3bda44ac",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.65,
        "y": 0.45
      },
      "kind": "image",
      "text": "Scientific diagram of base editing mechanism",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "63e04946-01ac-4119-b8ff-8eda13bedcd5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.5,
        "x": 0.07,
        "y": 0.48
      },
      "kind": "list",
      "text": "Differentiated platform: Novel IP with therapeutic advantages\nHighly effective single nucleotide editing (SNV): >50% of disease-causing mutations are SNVs\nModularity enriches multiplex editing: Expands beyond SNVs with improved safety",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4c7200a-3c7a-491a-ad72-8cd02564fbad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.05,
        "y": 0.07
      },
      "kind": "title",
      "text": "Transformational gene editing technology",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "115c1e7f-19d4-4df2-8596-a4f6aca56e54",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "title",
      "text": "Life Sciences Case Study",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "08846686-2411-4cd1-9a15-a549483d5ced",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 90,
      "from": 24,
      "beatId": "019debe1-68e8-744d-bb8c-31575e75a2a5",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": null,
      "evidence": "Segment deep dives: LS Solutions, Signals, Diagnostics, Repro Health, innovation",
      "position": 4,
      "confidence": 78,
      "parentBeatName": null,
      "parentBeatSlug": null
    },
    {
      "to": 105,
      "from": 24,
      "beatId": "019debe1-69ae-7785-8a5f-959d8f6cab55",
      "arcName": "The Transformation Tale",
      "arcSlug": "transformation-tale",
      "beatName": "The Bridge",
      "beatSlug": null,
      "evidence": "Segment growth drivers and operating model that bridge to LRP targets",
      "position": 3,
      "confidence": 65,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 90,
      "from": 80,
      "name": "Time Machine",
      "slug": "24-time-machine",
      "bestFor": "Vision casting, long-term strategy, investment pitches",
      "matchId": "019debe1-6b94-72cf-9862-70786e5c1d59",
      "evidence": "p80 'Medicine is rapidly changing' current→future; p86 'Right to Win'; p89 future tech; p90 supplemental upside",
      "position": 12,
      "objective": "Cast vision of precision-medicine future and Revvity's right to win",
      "structure": "Fast Forward to Success -> What Made It Possible -> Back to Today's Decision",
      "confidence": 68,
      "description": "Transport the audience to a future state where your solution has already succeeded"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}